MJ-26

MJ-26 is an inhibitor targeting Menin. MJ-26 has high binding affinity (Ki: 0.56 μM) and significant antiproliferative activity. MJ-26 works by inhibiting Menin-MLL interaction and inducing Menin protein degradation. MJ-26 has significant antitumor effects on acute myeloid leukemia (AML). MJ-26 can be used in AML research.

For research use only. We do not sell to patients.

  • Formula: C38H47N9O4S2
  • Molecular Weight:757.97
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All Epigenetic Reader Domain Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00